NCT01790451View on ClinicalTrials.gov

Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Prostate Cancer
Interventions
PROCEDURE

Irreversible Electroporation

Trial Locations (1)

1105 AZ

AMC University Hospital, Amsterdam

Sponsors

Collaborators (1)

Angiodynamics, Inc.
All Listed Sponsors
collaborator

Angiodynamics, Inc.

INDUSTRY

lead

Clinical Research Office of the Endourological Society

OTHER

NCT01790451 - Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans | Biotech Hunter | Biotech Hunter